ACTSI Newsletter
|
Trouble viewing this email? Click here
to view on the web.
| |
| |  | 
ACTSI Weekly eRoundup
September 22, 2017
|
| |
| | | | | Several ACTSI-supported researchers used existing data from ACTSI’s Center for Health Discovery & Well Being and the Morehouse and Emory Team up to Eliminate Health Disparities (META)-Health Study to build a cohort of over 1,400 healthy individuals residing in the Atlanta metropolitan area to learn more about the cardiovascular risk factors associated with living in a food desert. The findings were recently published in Circulation: Cardiovascular ... | | | | Read More | | |
|
| |
| | | | The Gilbert Family Foundation is pleased to announce a RFP for high-impact translational research in gene-targeting strategies that address the underlying genetic abnormalities in neurofibromatosis type 1 (NF1) and have the potential to eradicate the disease. Proposals will be accepted for Team Science Awards defined as collaborative research amongst investigators with experience in gene-targeting strategies in or outside the field of NF1. | | | | Read More | | |
| |
| | | | The call for proposals will fund empirical research studies to help us better understand how to build trust and mutual respect to meet vulnerable patients' health care needs. | | | | Read More | | |
| |
| | | | The program provides opportunities and support for investigators to use SNPRC nonhuman primate resources in highly focused, short-term studies with a high likelihood of enhancing the value, utility, feasibility and attractiveness of nonhuman primates for biomedical research. | | | | Read More | | |
| |
| | | | The Clinical and Translational Science Award (CTSA) hubs promote advances in translational research and training at participating medical research institutions. This funding opportunity will enable innovative collaborations among CTSA hubs to overcome system-wide barriers to translational effectiveness. | | | | Read More | | |
| |
| | | | This award is an opportunity for new and early stage investigators to pursue research programs of high interest to the NIBIB at the interface of engineering and/or the physical sciences with the life and/or behavioral sciences. The application of principles and techniques from engineering and the quantitative sciences such as physics, mathematics, chemistry and computer sciences is providing innovative technologies and novel methods to accelerate the pace of biomedical research, producing new understanding of disease mechanisms and translating these new discoveries to improve human health. | | | | Read More | | |
| |
| | | | The purpose of this program is to support Centers of Excellence for the sustainability of and to enhance interdisciplinary, biobehavioral research for scientists conducting research in multiple complex chronic conditions in human adult populations.
| | | | Read More | | |
| |
| | | | The program advances a mechanisms-focused, experimental medicine approach to behavior change research. Currently, awardees in the SOBC Research Network are developing, adapting, and testing experimental manipulations meant to engage specific health-behavior-related targets, developing assays intended to verify target engagement, showing that these putative targets can be influenced by a manipulation, and that thus changing target activity leads to behavior change. To encourage the adaptation, validation, and translation of these assays in a broader range of ongoing studies and populations, the NIH is now inviting applications to four available FOAs that involve using one or more of the SOBC Research Network assays. | | | | Read More | | |
| |
| | | | This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex. | | | | Read More | | |
| |
| | | | The program provides the nation's most comprehensive learning experience at the nexus of health, science, and policy in Washington, D.C. It is an outstanding opportunity for exceptional midcareer health professionals and behavioral and social scientists with an interest in health and health care policy. Fellows participate in the policy process at the federal level and use that leadership experience to improve health, health care, and health policy. | | | | Read More | | |
| |
| | | | The award provides funding for a one-year mentored sleep and circadian research project following a clinical sleep medicine fellowship. The award may be used to cover expenses associated with research and training, such as applicant salary support, supplies, participant incentives and other project or training costs. | | | | Read More | | |
| |
| | | | The initiative is a mentoring and career development grant of the Bone and Joint Initiative that aims to increase the pipeline of clinicians and basic scientists undertaking musculoskeletal research studies. | | | | Read More | | |
| |
| | | | Misconduct: Research Misconduct at the High School Level | | | | Read More | | |
| |
| | | | UCB has a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe diseases. Please join Georgia Bio's Emerging Leaders Network for a tour of the UCB Solution Accelerator. Attendees will experience a brief overview of the company, 15-30 minutes, and then tour onsite operations. | | | | Read More | | |
| |
| | | | NCATS announces opportunity for NIH intramural researchers to submit proposals to collaborate with Pfizer's Centers for Therapeutic Innovation (CTI). The program pairs NIH researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. Goals include identifying biologic compounds with activity in a pathway or target of interest to both an NIH intramural researcher and to Pfizer, and moving the compounds into the clinic to test them. | | | | Read More | | |
| |
| | | | The Road Runners Club of America developed the Kids Run the Nation Fund to assist running clubs, events, and schools that are interested in implementing or currently have a youth running program. | | | | Read More | | |
| |
| | | | The Food and Drug Administration (FDA) recently announced the inaugural meeting of FDA's first-ever advisory committee focusing specifically on patient-related issues. The Center for Devices and Radiological Health (CDRH) Patient Engagement Advisory Committee (PEAC) was established to provide perspective to the FDA about the patient experience, and suggest approaches for including patient input in FDA decisions. Unlike other advisory committees, PEAC is solely comprised of patients and caregivers. This meeting will bring together patients, patient organizations, FDA, industry, and other medical and scientific experts for a broader discussion on incorporating patient perspectives in the design, conduct, and reporting of medical device clinical trials. The FDA is interested in ensuring that the committee hears a broad range of patient perspectives, particularly from those who are underrepresented in clinical trials, and hope that you will join us at our inaugural meeting.
| | | | Read More | | |
| |
| | | | It has been known for some time that children raised in impoverished environments do not express genetic differences in cognitive ability to the same extent as children raised in middle class homes, a phenomenon known as the Scarr-Rowe interaction. Eric Turkheimer, PhD will summarize what is known about this phenomenon, focusing on new analyses of some classic twin datasets that have not previously been available. The goal of the new analyses is to emphasize the developmental processes that underlie modification of heritability and other quantitative genetic parameters. | | | | Read More | | |
| |
| | | | Emory's Office of Compliance presents how the 21st Century Cures Act affects mobile app review, and what to look out for in the contracts surrounding mobile app development and distribution. | | | | Read More | | |
| |
| | | | American Association for Cancer Research (AACR) and Minorities in Cancer Research (MICR) Distinguished Lectureship Series from 2:00-5:00 p.m. in Morehouse School of Medicine's NCPC Atrium
| | | | Read More | | |
| |
| | | | | | The 22nd Annual HeLa Women's Health Symposium at Morehouse School of Medicine's NCPC Auditorium and hosted by the Department of Obstetrics and Gynecology. | | | | Read More | | |
|
| |
| | | | A seminar presented by Maria Souden, PhD, MSI at 1:00 p.m. | | | | Read More | | |
| |
| | | | | The K-Club provides an educational forum to assist fellows and faculty. The discussion will be led by Gary Miller, PhD, professor and Associate Dean for Research, Rollins School of Public Health, Department of Environmental Health, Emory University. A light lunch will be provided at noon in Egleston, classrooms 5-7. Sponsored by Emory Department of Pediatrics and Department of Medicine, Atlanta Clinical & Translational Science ... | | | | Read More | | |
|
| |
| | | | Georgia Tech-IEN's 16th NanoFANS (Focusing on Advanced Nanobio Systems) Forum, for the first time on Emory's campus from 11:00 a.m.-2:30 p.m. at the Health Sciences Research Building Auditorium (HSRB). A box lunch is also included at no cost to the participants. The forum will feature Dr. YongTae (Tony) Kim, professor of Mechanical Engineering, Georgia Tech; Dr. Wilbur Lam, professor of Biomedical Engineering, Georgia Tech-Emory University; Dr. Hang Lu, Love Family Professor of Chemical & Biomolecular Engineering, Georgia Tech; and Dr. Fatih Sarioglu, professor of Electrical & Computer Engineering, Georgia Tech. | | | | Read More | | |
| |
| | | | NCATS launched the Biomedical Data Translator (Translator) program to accelerate biomedical translation for the research community. Through this program, NCATS will integrate existing biomedical data to help reveal new relationships within those data and identify novel opportunities for research. The initial focus of the program is to conduct data assessment and technical feasibility analyses for building a data "Translator" that integrates data sources and types ranging from patient level phenotypic data to molecular data relevant to understanding pathophysiology. To pressure test various aspects of feasibility, cross-cutting research questions that have been difficult to address by other means will be addressed in demonstration projects to evaluate the functionality of the newly integrated data. | | | | Read More | | |
| |
| | | | Registration is now open for the workshop to explore uses of common ontologies at the Michigan League. Explore new and existing uses of common ontologies to support creation, sharing, and analysis of clinical data at the 6th Annual Workshop of the Clinical & Translational Science Ontology Group. | | | | Read More | | |
| |
| | | | NCATS Program Officer Bobbie Ann Austin, PhD, who oversees NCATS' Drug Development Partnership programs, will participate in two panel. Additional featured speakers will address the latest indications for repurposing, rescuing and repositioning existing drugs to explore the newest innovations. | | | | Read More | | |
| |
| For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456. |
| |
|
